Advertisement

Topics

Companies Related to "Kyowa Hakko Kirin signs drug discovery deal with" [Most Relevant Company Matches] RSS

09:49 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Kyowa Hakko Kirin signs drug discovery deal with" found in our extensive corporate database of over 50,000 company records.

Showing "Kyowa Hakko Kirin signs drug discovery deal with" Companies 1–25 of 4,600+

Extremely Relevant

Kyowa Hakko Kirin Co., Ltd.


Kyowa Hakko Kirin Co. Ltd.

Kyowa Pharmaceutical, Inc

From its foundation in 1949, Kyowa Hakko has been a global leader in the pharmaceutical industry. Today, Kyowa's expertise extends to the United States through Kyowa Pharmaceutical, Inc. headquartered in Princeton, New Jersey.


Kyowa Hakko

Kyowa Hakko USA

Kyowa Hakko, USA Inc.

ArQule, Inc. and Daiichi Sankyo Company, Limited

On December 19, 2008, ArQule and Daiichi Sankyo, Co., Ltd. signed a license, co-development and co-commercialization agreement to co-develop tivantinib in the U.S., Europe, South America and the rest of the world, excluding Japan, China (including Hong Kong), South Korea and Taiwan, where Kyowa Hakko Kirin Co., Ltd. has exclusive rights for development and...

Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals is a private, venture-backed RNAi-focused biopharmaceutical company developing novel therapeutic agents and related drug delivery systems in oncology and other disease areas based on its proprietary Dicer Substrate Technology™ platform and Dicer Substrate siRNA (DsiRNA) molecules. Dicer Substrate Technology™ is a second ge...

Relevant

Kirin Brewery Company Limited

Drug Discovery

NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The company is currently advancing two Phase 3 registration programs. Teduglutide, a proprietary analog of GLP-2, is being evaluated as GATTEX® in a Phase 3 registration study known as STEPS for intestinal failure associated with shor...

Targazyme, Inc.

Targazyme, Inc. is a privately held biotechnology company based in San Antonio, TX with additional offices in San Diego, CA and Basel, Switzerland. Its key technology platforms (TZ101 and TZ102) are designed to improve the homing and engraftment of a wide variety of therapeutic cells to target tissues. Applications in development include hematopoietic stem...

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervous system disorders. History of Successful Drug Discovery NPS has a history of successful drug discovery. With one approved product on the market and several more in development, NPS's discovery capab...

Alliance for Biosecurity

The Alliance for Biosecurity was formed in June of 2005 by biopharmaceutical companies and the Center for Biosecurity of the University of Pittsburgh Medical Center. Alliance members are committed to partnering with government and promoting a new era in the prevention and treatment of severe infectious diseases - particularly those that present global security challenges - through innovative and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successful contract research business, offering complete drug discovery services in many therapeutic areas to pharmaceutical and biotech clients. We provide resources and expertise to direct complete discovery...

Drug Discovery Industr

Welcome to Drug Discovery Online, the first Internet site devoted exclusively to drug discovery and early-stage drug development.Drug Discovery Online covers drug discovery like no other Internet site. Each day we present the most interesting, useful feature stories, case studies, industry news, and newswire feeds related to the science and business of discovering new drugs. Throughout the year Dr...

SmartSign

SmartSign is one of America's fastest growing e-commerce companies and parent of JustBathroomSigns, MySafetySign, and more than 50 other sites. The company manufactures and distributes a wide range of signs, tags, mats, and labels. By positioning “signs as solutions,” SmartSign has taken a novel approach to ordering signs. Through highly targeted, ...

Deal Labs, Inc.

Deal Labs raises capital for private companies, public companies, and pooled investment funds and partnerships including real estate. Deal Labs selectively targets the type of retail and institutional investors who are believed to be best suited for a particular investment, thereby substantially improving and expediting the capital raising process. Rather ...

Beryllium

Beryllium is shaping the future of collaborative drug discovery. Our proven teams of drug discovery professionals are passionate about unlocking the therapeutic potential of both genetically- and clinically-validated drug targets, and in developing new therapeutic modalities. We work in partnership with our clients to address the most difficult scientific ...

Archemix

Archemix is a drug discovery and development company founded by experts in molecular biology and drug discovery, and backed by experienced biotech investors. Using proprietary technologies, we create biotherapeutics and drug discovery tools. Working independently and through alliances with pharmaceutical partners, we are committed to driving the science of making better medicines.

Kalypses Incorporated

Kalypsys, Inc. is a biopharmaceutical company pioneering an industrialized approach to pathway-based drug discovery. Kalypsys implements discovery programs across a broad number of therapeutic areas using its highly automated and integrated suite of discovery technologies in biology, chemistry and informatics. By using a pathway-based discovery strategy together with these integrated technologies,...

PharmaVentures Ltd

PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances. Our unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes us uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures ...

Kirin Brewery Co.,LTD

Nil

Hematech, Inc.

Hematech, LLC was founded in 1998 and has its corporate headquarters in Sioux Falls, SD. In 1999, Hematech and the Pharmaceutical Division of the Kirin Brewery Company began a research collaboration to develop a bovine system for production of human polyclonal antibodies. The collaboration brought together Kirin's human artificial chromosome (HAC) and gene targeting technologies and Hematech's bov...

Discovery Partners

Discovery Partners has five operational centers of excellence dedicated to servicing the drug discovery market: (1) Discovery Instrumentation; develops, manufactures, and markets IRORI equipment and consumables for the generation of chemical libraries. The first two NanoKan™ Ultra High-throughput Systems, which allow synthesis of up to one million new compounds per year, were installed at Aventi...

Collaborative Drug Discovery

CDD hosts the most widely used drug discovery cloud platform on the market. "CDD Vault" is the secure, private industrial-strength database combining traditional drug discovery informatics (registration and SAR) with social networking capabilities. "CDD Collaborate" enables real-time collaboration by securely exchanging selected confidential data with external researchers. "CDD Public" has unique ...


More From BioPortfolio on "Kyowa Hakko Kirin signs drug discovery deal with"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks